MedTrace Logo

Advanced Metagenomic Analysis of Human Colonic Microbiota in Patients With Chronic GI Disorders

NCT01099111 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 225

Last updated 2014-05-22

Study results available
· View outcomes & findings →

Summary

This clinical trial hypothesize that Gut Microbiota (bacteria, viruses, fungi)play a major role in the occurrence and progression of many chronic gastrointestinal diseases like Irritable Bowel Syndrome, Inflammatory Bowel Diseases and Colo-Rectal Cancer.

Hence, aims to study the spectrum of such microbiota in these patients as compared to normal subjects, by utilizing metagenomic techniques rather than cultural methods.

Conditions

  • Irritable Bowel Syndrome
  • Colitis, Ulcerative
  • Crohn Disease
  • Colonic Neoplasms

Sponsors & Collaborators

  • King AbdulAziz City for Science and Technology

    collaborator OTHER

  • King Fahad Medical City

    lead OTHER_GOV

Principal Investigators

  • Ahmed O AlOmair, MD · KFMC

  • Ali Al Shanqeeti, MD · KACST

Eligibility

Min Age
16 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-07-31
Primary Completion
2012-01-31
Completion
2012-03-31

Countries

  • Saudi Arabia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01099111 on ClinicalTrials.gov